Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Alzheimer’s disease could be slowed by boosting a certain protein in the brain, researchers say
Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The University of Cincinnati researchers and an Alzheimer's Association expert weigh in.
Eli Lilly Gets Japan OK for Kisunla Alzheimer's Disease Drug
Eli Lilly on Tuesday said Japan's Ministry of Health, Labour and Welfare Japan approved Kisunla for adults with early symptomatic Alzheimer's, including those with mild cognitive impairment as well as people with the mild dementia stage of the memory-robbing disease.
Why It’s So Important to Detect Alzheimer’s Disease Early
A diagnosis in the early stages may allow you to start treatments that can slow disease progression.
A New Dawn for Alzheimer’s Disease
We are at a turning point in the fight against Alzheimer’s disease with the emergence of disease-modifying therapies for early symptomatic stages of the disease and availability of diagnostic tools providing patients with new hope.
World Alzheimer's Day: How To Slow Down The Progression Of Alzheimer
Alzheimer’s disease is primarily caused by the buildup of amyloid plaques and neurofibrillary tangles in the brain, which disrupt communication between neurons and ultimately lead to their death. Remember,
World Alzheimer’s Day | New drugs, early detection offers hope for the patients
Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and durable disease management, writes Vanita Srivastava.
17m
on MSN
Eli Lilly's Alzheimer's drug approved in Japan
Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing ...
27m
Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease
The Ministry of Health, Labour and Welfare Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks ...
18h
Astrocytes study identifies a new therapeutic target for Alzheimer's disease
Worldwide, at least 50 million people are believed to be living with a form of dementia. Alzheimer's disease is the most ...
Techno-Science on MSN
4h
🧬 A link between light pollution and Alzheimer's disease?
Are nights truly dark? Not always. Indeed, some areas remain constantly illuminated, and this light could have unexpected ...
5h
Mental health and Alzheimer's disease: Here's how depression affects brain functions
Understanding the link between mental health and Alzheimer's is crucial, as studies show that depression may raise the risk ...
News Medical on MSN
23h
Calcium channel blockers show potential to restore cerebral blood flow in Alzheimer's disease
Blocking calcium channels in brain capillaries may enhance blood flow and alleviate early-stage
Alzheimer's
damage, new ...
Lock Haven
4h
Alzheimer’s Disease: Healthy living for your brain and body
Penn State Extension is offering a Healthy Living Brain and Body Educational workshop on Oct. 1 from 4-5 p.m. at the Friendship Community Library 127 Main St. Beech Creek, PA 16822 To register, ...
Medpage Today on MSN
7d
For Your Patients: How Is Alzheimer's Disease Diagnosed?
There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...
The Healthy on MSN
10h
13 Things Neurologists Do to Help Prevent Alzheimer’s Disease
Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
World
dementia
diabetes
University of Texas Health Science Center at San Antonio
SGLT2
Feedback